TVGN
Tevogen Bio Holdings Inc
NASDAQ: TVGN · HEALTHCARE · BIOTECHNOLOGY
$6.64
+3.43% today
Updated 2026-04-30
Market cap
$27.03M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-8.08
Dividend yield
—
52W range
$4 – $76
Volume
0.2M
Tevogen Bio Holdings Inc (TVGN) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Operating cash flow | $-5.27M | $-8.66M | $-8.17M | $-12.00M |
| Capital expenditures | $109727.00 | $479042.00 | $133000.00 | $0.00 |
| Depreciation | — | — | — | — |
| Stock-based comp | $582408.00 | $4.58M | $0.00 | $40.76M |
| Free cash flow | $-5.38M | $-9.13M | $-8.30M | $-12.00M |
| Investing cash flow | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Share repurchases | — | — | — | — |
| Debt repayment | — | — | — | — |
| Net change in cash | — | — | — | — |